Cargando…
Analysis of biopsy-proven nephrotic syndrome in Tibetan patients
Autores principales: | Huang, Rongshuang, Liu, Jing, Shi, Min, Gou, Shenju, Ma, Liang, Fu, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8769079/ https://www.ncbi.nlm.nih.gov/pubmed/35032161 http://dx.doi.org/10.1097/CM9.0000000000001721 |
Ejemplares similares
-
Catheter failure and mortality in hemodialysis patients with the tunneled-cuffed catheter tip positioned in the inferior vena cava
por: Cheng, Lu, et al.
Publicado: (2022) -
Clinical and histopathological predictors of rapid kidney function decline in patients with biopsy-proven diabetic kidney disease
por: Zhao, Yiyang, et al.
Publicado: (2023) -
Urinary Exosomal MicroRNA Signatures in Nephrotic, Biopsy-Proven Diabetic Nephropathy
por: Lee, Wen-Chin, et al.
Publicado: (2020) -
Corticosteroid reduction by addition of cetirizine and montelukast in biopsy-proven minimal-change nephrotic syndrome concomitant with allergic disorders
por: Oshima, Yoichi, et al.
Publicado: (2020) -
Nine per cent of biopsy‐proven lentigo maligna lesions are reclassified as lentigo maligna melanoma after surgery
por: Zoutendijk, J., et al.
Publicado: (2019)